LMN-201 for Prevention of C. Difficile Infection Recurrence

NCT05330182 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

375

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridioides Difficile Infection

Interventions

DRUG: LMN-201
DRUG: Placebo

Sponsor

Lumen Bioscience, Inc.

Collaborators

[object Object]